Therapeutic effects of a human antiflagella monoclonal antibody in a neutropenic murine model of Pseudomonas aeruginosa pneumonia (Q35808176)

10 August 2017

Therapeutic effects of a human antiflagella monoclonal antibody in a neutropenic murine model of Pseudomonas aeruginosa pneumonia (English)

1 reference

10 August 2017

1 reference

1 reference

Pseudomonas aeruginosa

object named as

Pseudomonas aeruginosa

1 reference

1 reference

K Oishi

1

1 reference

10 August 2017

F Sonoda

2

1 reference

10 August 2017

A Iwagaki

3

1 reference

10 August 2017

P Ponglertnapagorn

4

1 reference

10 August 2017

K Watanabe

5

1 reference

10 August 2017

T Nagatake

6

1 reference

10 August 2017

A Siadak

7

1 reference

10 August 2017

M Pollack

8

1 reference

10 August 2017

K Matsumoto

9

1 reference

10 August 2017

language of work or name

English

0 references

publication date

1 February 1993

1 reference

Antimicrobial Agents and Chemotherapy

10 August 2017

1 reference

10 August 2017

37

1 reference

10 August 2017

2

1 reference

10 August 2017

164-170

1 reference

Bacteremic nosocomial pneumonia. Analysis of 172 episodes from a single metropolitan area

10 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=187632

The virulence of Pseudomonas aeruginosa

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=187632

Differentiation of the major flagellar antigens of Pseudomonas aeruginosa by the slide coagglutination technique.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=187632

Flagella and motility alterations in Pseudomonas aeruginosa strains from patients with cystic fibrosis: relationship to patient clinical condition

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=187632

Opsonophagocytosis of Pseudomonas aeruginosa treated with antiflagellar serum.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=187632

Polyclonal and monoclonal antibody therapy for experimental Pseudomonas aeruginosa pneumonia

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=187632

The efficient production of stable, human monoclonal antibody-secreting hybridomas from EBV-transformed lymphocytes using the mouse myeloma X63-Ag8.653 as a fusion partner.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=187632

In vitro and in vivo antibacterial activities of AT-4140, a new broad-spectrum quinolone

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=187632

In vitro activity of AT-4140 against clinical bacterial isolates

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=187632

Pharmacokinetics of a novel quinolone, AT-4140, in animals

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=187632

Generation and characterization of murine antiflagellum monoclonal antibodies that are protective against lethal challenge with Pseudomonas aeruginosa.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=187632

Inhibitory activity on bacterial motility and in vivo protective activity of human monoclonal antibodies against flagella of Pseudomonas aeruginosa

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=187632

A protective human monoclonal antibody directed to the outer core region of Pseudomonas aeruginosa lipopolysaccharide

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=187632

Antibacterial and Protective Properties of Monoclonal Antibodies Reactive with Escherichia coli O111:B4 Lipopolysaccharide: Relation to Antibody Isotype and Complement-Fixing Activity

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=187632

Effects of a human antiflagellar monoclonal antibody in combination with antibiotics on Pseudomonas aeruginosa infection

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=187632

Effects of the combination of lipopolysaccharide-specific monoclonal antibodies and sparfloxacin against Pseudomonas aeruginosa pneumonia in neutropenic mice

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=187632

Specificity of opsonic antibodies to enhance phagocytosis of Pseudomonas aeruginosa by human alveolar macrophages

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=187632

Hospital-acquired gram-negative rod pneumonias: an overview.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=187632

Pulmonary host defenses. I. Analysis of protein and lipids in bronchial secretions and antibody responses after vaccination with pseudomonas aeruginosa

25 September 2018

1 reference

12 December 2020

Experimental studies of the pathogenesis of infections due to Pseudomonas aeruginosa: immunization using divalent flagella preparations

1 reference

12 December 2020

Protection against Pseudomonas aeruginosa infection by passive transfer of anti-flagellar serum

1 reference

12 December 2020

Flagella, motility and invasive virulence of Pseudomonas aeruginosa

1 reference

12 December 2020

Oral ciprofloxacin and a monoclonal antibody to lipopolysaccharide protect leukopenic rats from lethal infection with Pseudomonas aeruginosa

1 reference

12 December 2020

Flagellar antibody stimulated opsonophagocytosis of Pseudomonas aeruginosa associated with response to either a- or b-type flagellar antigen

1 reference

12 December 2020

Protection against mucoid Pseudomonas aeruginosa in rodent models of endobronchial infections

1 reference

12 December 2020

Therapy of Established Experimental Pseudomonas aeruginosa Infections with Oral Ciprofloxacin and Five Human Monoclonal Antibodies against Lipopolysaccharide Antigens

1 reference

12 December 2020

Pharmacodynamic and Protective Properties of a Murine Lipopolysaccharide-Specific Monoclonal Antibody in ExperimentalPseudomonas aeruginosaPneumonia in Mice

1 reference

12 December 2020

Pseudomonas pneumonia. A retrospective study of 36 cases

1 reference

12 December 2020

Identifiers

DOI

10.1128/AAC.37.2.164

1 reference

10 August 2017

1 reference

10 August 2017

PubMed publication ID

8383936

1 reference